Company Comparison
Ginkgo Bioworks vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Ginkgo Bioworks | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | 2008 | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | $290M | $45M |
| Valuation | $4.2B | — |
What They Build
Ginkgo Bioworks
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Ginkgo Bioworks
Sector Overlap
Both Ginkgo Bioworks and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.